How common symptomatic gastroesophageal reflux is in Czech children aged 8–9 and 12–13
Official title: Prevalence of Symptomatic Gastroesophageal Reflux Disease in Children in the Czech Republic
Run by University Hospital, Motol · NCT07482969 · Data updated 2026-11-12
This project will see how common symptomatic GERD is in Czech children aged 8–9 and 12–13 by using school questionnaires and follow-up medical testing for kids who report reflux symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 8 Years to 13 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University Hospital, Motol Academic / other |
| Locations | 1 site (Prague) |
| Status | Recruiting |
| Started | December 20, 2025 |
| Main results expected | December 30, 2028 |
| Study ends | December 30, 2028 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT07482969 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 8–9 or 12–13 who attend participating schools in the Czech Republic and can complete the web questionnaire and diagnostic testing, and who do not have psychomotor impairment, are the intended participants.
✕Probably not a fit
Children who are asymptomatic, live outside the Czech Republic, cannot travel to Prague for diagnostic testing, or have psychomotor impairment are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This population-based, cross-sectional study recruits children aged 8–9 and 12–13 through selected schools in the Czech Republic and begins with a secure web-based questionnaire about reflux symptoms and related factors. Children reporting heartburn (pyrosis) or regurgitation enter a stepwise diagnostic pathway starting with a standardized 14-day proton pump inhibitor (PPI) trial including 14 days of baseline symptom recording and 14 days on PPI at age-appropriate doses. Those without a clear response undergo upper endoscopy to look for esophagitis or complications, and if endoscopy is normal or inconclusive they receive 24-hour pH-impedance monitoring to quantify reflux and symptom association. Final classifications (confirmed GERD, reflux hypersensitivity, or functional pyrosis) are combined with validated quality-of-life measures to produce population prevalence estimates and explore symptom burden and risk factors.
Why it matters
Potential benefit: If successful, the study could clarify how many children have true GERD versus other causes of reflux symptoms, helping doctors target treatment and avoid unnecessary long-term PPI use.
How similar studies have gone: Similar population-based questionnaires combined with guideline-based diagnostic pathways have been used in other pediatric populations and produced credible prevalence data, so the approach is well-established though country-specific data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age group of 8 - 9 years and 12 - 13 years * school attendance ability Exclusion Criteria: * psychomotor impairment
Where it's running
-
Motol University Hospital
Prague, Czechia Recruiting
Study contacts
- Study coordinator: Tereza Lerchova
- Email: terezadrskova@gmail.com
- Phone: +420775201573
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Medical AI fine-tuning platform for major diseases
This study tests a smart AI system that uses hospital data to help diagnose and guide care for patients with chronic gastritis, gastric cancer, reflux, coronary artery disease, or stroke.
-
Nissen‑Sleeve versus Roux‑en‑Y gastric bypass for reflux in people with severe obesity
This trial tests whether Nissen‑Sleeve gastrectomy or Roux‑en‑Y gastric bypass better controls GERD symptoms in adults who are eligible for bariatric surgery due to severe obesity.
-
Breathing muscle training for gastroesophageal reflux (GERD)
This trial will test whether a 3-month inspiratory muscle training program helps adults with GERD strengthen their breathing muscles and reduce reflux symptoms.
-
Evaluating hiatal closure for treating early GERD
This study is testing if a new surgical method called hiatal closure can help people with early GERD feel better by fixing the problem with their esophagus.
-
Validation of a cough monitoring system
This study is testing a new wearable device that tracks coughs in patients aged 2 and older to see if it can help doctors better understand and manage respiratory issues.
-
Endoscopic anti-reflux treatment with APC for people with GERD
This trial will test whether ARAT—an endoscopic anti-reflux procedure using argon plasma coagulation (APC)—can reduce chronic heartburn and acid reflux in adults who have a positive pH test and normal esophageal manometry.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.